Europe - Frankfurt Stock Exchange - FRA:AFX - DE0005313704 - Common Stock
The current stock price of AFX.DE is 39.44 EUR. In the past month the price decreased by -2.81%. In the past year, price decreased by -18.24%.
ChartMill assigns a fundamental rating of 5 / 10 to AFX.DE. AFX.DE is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average.
Over the last trailing twelve months AFX.DE reported a non-GAAP Earnings per Share(EPS) of 1.61. The EPS decreased by -19.9% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 6.34% | ||
| ROA | 4.15% | ||
| ROE | 6.67% | ||
| Debt/Equity | 0.27 |
22 analysts have analysed AFX.DE and the average price target is 49.78 EUR. This implies a price increase of 26.21% is expected in the next year compared to the current price of 39.44.
For the next year, analysts expect an EPS growth of 24.48% and a revenue growth 4.23% for AFX.DE
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| 2M6.DE | MEDTRONIC PLC | 17.35 | 107.89B | ||
| 1SHL.MI | SIEMENS HEALTHINEERS AG | 19.62 | 52.88B | ||
| SHL.DE | SIEMENS HEALTHINEERS AG | 19.37 | 52.23B | ||
| PHI1.DE | KONINKLIJKE PHILIPS NV | 17.34 | 24.72B | ||
| PHIA.AS | KONINKLIJKE PHILIPS NV | 17.32 | 24.69B | ||
| 1PHIA.MI | KONINKLIJKE PHILIPS NV | 17.36 | 24.74B | ||
| BIM.PA | BIOMERIEUX | 27.1 | 12.38B | ||
| OBCK.DE | OTTOBOCK SE & CO KGAA | 142.55 | 4.29B | ||
| DIA.MI | DIASORIN SPA | 22.54 | 4.17B | ||
| DRW3.DE | DRAEGERWERK AG - PREF | 13.62 | 1.65B | ||
| DRW8.DE | DRAEGERWERK AG | 10.7 | 1.29B | ||
| ELN.MI | EL.EN. SPA | 22.41 | 1.15B |
Carl Zeiss Meditec AG engages in the development, manufacture, and marketing of medical devices. The company is headquartered in Jena, Thueringen and currently employs 5,784 full-time employees. The company went IPO on 2000-03-20. The firm offers complete solutions to diagnose and treat ophthalmic diseases, visualization solutions for microsurgery and other technologies, such as intraoperative radiotherapy. The firm operates in two segments: ophthalmic devices and microsurgery. The Ophthalmic Devices segment comprises activities in ophthalmology, such as intraocular lenses, surgical visualization solutions and medical laser and diagnostic systems. The Microsurgery segment includes activities of neuro, ear, nose, and throat surgery, as well as the activities in the field of intraoperative radiation. Its products include zeiss corneal photographers, slit lamps and accessories, data management software, zeiss intraocular lenses, optical biometers, optical coherence tomography systems, ophthalmic microscopes, refractive lasers are among others. The firm offers related support services.
CARL ZEISS MEDITEC AG - BR
Goeschwitzer Strasse 51-52
Jena THUERINGEN DE
Employees: 5730
Phone: 493641220331
Carl Zeiss Meditec AG engages in the development, manufacture, and marketing of medical devices. The company is headquartered in Jena, Thueringen and currently employs 5,784 full-time employees. The company went IPO on 2000-03-20. The firm offers complete solutions to diagnose and treat ophthalmic diseases, visualization solutions for microsurgery and other technologies, such as intraoperative radiotherapy. The firm operates in two segments: ophthalmic devices and microsurgery. The Ophthalmic Devices segment comprises activities in ophthalmology, such as intraocular lenses, surgical visualization solutions and medical laser and diagnostic systems. The Microsurgery segment includes activities of neuro, ear, nose, and throat surgery, as well as the activities in the field of intraoperative radiation. Its products include zeiss corneal photographers, slit lamps and accessories, data management software, zeiss intraocular lenses, optical biometers, optical coherence tomography systems, ophthalmic microscopes, refractive lasers are among others. The firm offers related support services.
The current stock price of AFX.DE is 39.44 EUR. The price decreased by -0.55% in the last trading session.
CARL ZEISS MEDITEC AG - BR (AFX.DE) has a dividend yield of 1.39%. The yearly dividend amount is currently 0.6.
AFX.DE has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on AFX.DE.
CARL ZEISS MEDITEC AG - BR (AFX.DE) has a market capitalization of 3.53B EUR. This makes AFX.DE a Mid Cap stock.